Cipher Capital’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-11,464
Closed -$1.52M 474
2022
Q2
$1.52M Buy
+11,464
New +$1.56M 0.34% 101
2020
Q4
Sell
-26,467
Closed -$3.03M 506
2020
Q3
$3.03M Buy
+26,467
New +$3.13M 0.4% 68
2019
Q4
Sell
-31,989
Closed -$3.42M 527
2019
Q3
$3.42M Buy
+31,989
New +$3.28M 0.27% 130
2018
Q4
Sell
-14,084
Closed -$1.52M 545
2018
Q3
$1.52M Buy
14,084
+10,482
+291% +$1.15M 0.28% 112
2018
Q2
$396K Sell
3,602
-24,257
-87% -$2.53M 0.08% 302
2018
Q1
$2.79M Sell
27,859
-50,057
-64% -$5.13M 0.34% 84
2017
Q4
$7.67M Buy
77,916
+52,180
+203% +$4.95M 0.61% 20
2017
Q3
$2.41M Sell
25,736
-60,576
-70% -$6.43M 0.18% 210
2017
Q2
$9.59M Buy
86,312
+44,864
+108% +$4.74M 0.75% 7
2017
Q1
$4.07M Sell
41,448
-71,955
-63% -$6.86M 0.3% 101
2016
Q4
$10.4M Buy
+113,403
New +$9.77M 0.7% 4
2016
Q3
Sell
-6,526
Closed -$531K 671
2016
Q2
$531K Sell
6,526
-16,019
-71% -$1.22M 0.04% 538
2016
Q1
$1.61M Buy
+22,545
New +$1.51M 0.15% 235
2015
Q4
Sell
-3,962
Closed -$244K 565
2015
Q3
$244K Buy
+3,962
New +$277K 0.03% 476
2015
Q2
Sell
-6,500
Closed -$500K 521
2015
Q1
$500K Buy
+6,500
New +$465K 0.08% 354

Other funds holding DGX

Cipher Capital's DGX Position: Q3 2022 in Review

Cipher Capital sold out of Quest Diagnostics (DGX) in Q3 2022, closing a stake of 11,464 shares — an estimated $1.52M sold.

Cipher Capital first reported a position in DGX in Q1 2015 and held it in 15 quarters. The position peaked at $10.4M in Q4 2016. 808 funds tracked by Wall St. Rank hold DGX as of Q3 2022.

  • Cipher Capital reported no remaining Quest Diagnostics position as of Q3 2022 after selling out during the quarter.
  • Cipher Capital sold 11,464 Quest Diagnostics shares in Q3 2022, an estimated $1.52M.
  • Cipher Capital first reported a position in Quest Diagnostics in Q1 2015 and held it in 15 quarters.
  • Cipher Capital's Quest Diagnostics position peaked at $10.4M in Q4 2016.
  • 808 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2022.

Based on Cipher Capital's 13F filing for Q3 2022, filed 14 Nov 2022.